PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 1, 2026Frontiers in Bioscience-Landmark1 citationsOpen Access

The Gut-Bone Axis: Molecular Mechanisms and Therapeutic Perspectives in Skeletal Homeostasis

ZYZhijun YeZSZhibin SongDYDun Yang

Key Points

  • This review aims to detail the mechanisms by which gut health influences bone metabolism and highlights potential therapeutic interventions.
  • Synthesis of recent research on gut-bone crosstalk mechanisms, including metabolite signaling and immune modulation.
  • Evaluation of microbiome-targeted interventions and their implications for conditions like osteoporosis.
  • Analysis of signaling pathways such as FXR and their roles in bone cell function as influenced by gut factors.
  • Identified key microbial metabolites like SCFAs that affect bone remodeling through immunologic and hormonal pathways.
  • Discussed the potential of engineered microbial therapies to regulate bone metabolism.
  • Proposed a shift from traditional calcium-focused approaches to integrated strategies that consider gut health.

Abstract

The gut-bone axis represents a paradigm shift in our understanding of skeletal biology, revealing how the gastrointestinal system and its microbial inhabitants profoundly influence bone homeostasis through complex bidirectional communication. This comprehensive review synthesizes recent high-impact research to elucidate the multifaceted mechanisms underlying gut-bone crosstalk, including microbial metabolite signaling, gut barrier integrity, immune modulation, and endocrine regulation. We examine how short-chain fatty acids (SCFAs), tryptophan metabolites, and bile acid derivatives modulate bone remodeling through epigenetic, immunologic, and hormonal pathways. The translational implications of these findings for the management of osteoporosis, osteoarthritis, and inflammatory bone disorders are critically evaluated, with particular emphasis on microbiome-targeted interventions, gut hormone-based therapies, and innovative approaches such as engineered microbial therapeutics. Furthermore, we explore the roles of farnesoid X receptor (FXR) signaling, G protein-coupled receptor activation, and mitochondrial function in bone cells as modulated by gut-derived factors. This review provides a framework for developing novel diagnostic and therapeutic strategies that target the gut-bone axis, highlighting the transition from traditional calcium-centric bone health paradigms toward integrated microbiome-targeted approaches that address the systemic nature of bone metabolism regulation.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ye et al. (2026) studied this question.

synapsesocial.com/papers/6a1d234302fbce9130638e7fhttps://doi.org/10.31083/fbl46147
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Randomised clinical trial: L actobacillus reuteri DSM 17938 vs. placebo in children with acute diarrhoea ‐ a double‐blind study2012 · 110 citations
  2. 2Differences in Tumor Microenvironment Dictate T Helper Lineage Polarization and Response to Immune Checkpoint Therapy2019 · 390 citations
  3. 3Alloreactive T cells deficient of the short-chain fatty acid receptor GPR109A induce less graft-versus-host disease2021 · 58 citations
  4. 4Timing of Interleukin-4 Stimulation of Macrophages Determines Their Anti-Microbial Activity during Infection with Salmonella enterica Serovar Typhimurium2023 · 7 citations
  5. 5Phytosterols Protect against Osteoporosis by Regulating Gut Microbiota2023 · 22 citations